Monday, March 30, 2026

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

Republican Senators Threaten to Block Trump’s Fed Nominees Over Powell Probe

Republican senators broke ranks with President Donald Trump on Monday, joining Democrats in condemning the...

Tuesday, January 13, 2026, 03:03:00 PM

California Files Legal Challenge Against Trump Tariffs

California has filed a lawsuit against the Trump administration in what marks the first time...

Sunday, April 20, 2025, 11:25:00 AM

Ackman Now Calls For Full 90-Day Pause On Tariffs, Bringing Down To 10%

Billionaire investor Bill Ackman is once again issuing dire warnings about President Donald Trump’s tariff...

Monday, April 14, 2025, 11:20:00 AM

Kevin O’Leary and Grant Cardone Opt Out Of New York After Donald Trump’s $355 Million Fraud Verdict

Former FTX spokesperson and “Shark Tank” investor Kevin O’Leary has a lot of feelings about...

Thursday, February 22, 2024, 11:01:00 AM

Oil Prices Shrug Off Trump’s Second Iran Deadline Extension

President Donald Trump extended his pause on US strikes against Iranian power plants for a...

Friday, March 27, 2026, 07:35:40 AM